Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Amcol International Corp.
Nano-bentonites inactivate viruses
October 9th, 2005
Amcol International Corp. (ACO) announced that test results of recently discovered anti-viral properties of nano bentonites will be jointly presented with Retroscreen Virology, Ltd., a London-based research and testing facility. In this study, laboratory tests have demonstrated that HIV, influenza and Avian influenza viruses can be inactivated using specially modified bentonites. Additional tests will be conducted with other viruses. Jerry Darlington, Amcol technical director and Charlotte Chan, Research Scientist, will be presenting the results at a poster session being at the Second European Influenza Conference in Malta. Scientists, healthcare...
Source: Managed Care Law Weekly (2005-10-09)
|
